John R. P. Knight

2.6k total citations
27 papers, 1.1k citations indexed

About

John R. P. Knight is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, John R. P. Knight has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in John R. P. Knight's work include RNA and protein synthesis mechanisms (7 papers), RNA modifications and cancer (5 papers) and Autophagy in Disease and Therapy (5 papers). John R. P. Knight is often cited by papers focused on RNA and protein synthesis mechanisms (7 papers), RNA modifications and cancer (5 papers) and Autophagy in Disease and Therapy (5 papers). John R. P. Knight collaborates with scholars based in United Kingdom, United States and Italy. John R. P. Knight's co-authors include C. J. Green, S. Simpkin, Sophie V. Precious, Jo Milner, Anne E. Willis, Simon J. Allison, C. Mark Smales, Owen J. Sansom, Anne Roobol and Amandine Bastide and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Genes & Development.

In The Last Decade

John R. P. Knight

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. P. Knight United Kingdom 19 580 199 152 147 96 27 1.1k
Cristiana Valle Italy 24 624 1.1× 55 0.3× 28 0.2× 112 0.8× 211 2.2× 57 1.5k
Yukang Yuan China 22 571 1.0× 147 0.7× 220 1.4× 4 0.0× 135 1.4× 73 1.2k
Minna Niittykoski Finland 14 335 0.6× 65 0.3× 46 0.3× 4 0.0× 88 0.9× 24 819
Yongqin Wu China 15 833 1.4× 99 0.5× 72 0.5× 10 0.1× 83 0.9× 27 1.5k
Jessie M. Cameron Canada 24 908 1.6× 92 0.5× 17 0.1× 59 0.4× 120 1.3× 46 1.4k
Nicola Beindorff Germany 18 146 0.3× 21 0.1× 69 0.5× 81 0.6× 131 1.4× 53 986
Patrick J. Gillespie United States 10 1.0k 1.8× 60 0.3× 73 0.5× 7 0.0× 156 1.6× 16 1.9k
Jun Tanaka Japan 16 427 0.7× 83 0.4× 45 0.3× 8 0.1× 274 2.9× 41 1.1k
Françoise Roux France 18 265 0.5× 20 0.1× 162 1.1× 46 0.3× 196 2.0× 47 951
Douglas J. Lamont United Kingdom 22 829 1.4× 54 0.3× 74 0.5× 13 0.1× 186 1.9× 38 1.4k

Countries citing papers authored by John R. P. Knight

Since Specialization
Citations

This map shows the geographic impact of John R. P. Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. P. Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. P. Knight more than expected).

Fields of papers citing papers by John R. P. Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. P. Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. P. Knight. The network helps show where John R. P. Knight may publish in the future.

Co-authorship network of co-authors of John R. P. Knight

This figure shows the co-authorship network connecting the top 25 collaborators of John R. P. Knight. A scholar is included among the top collaborators of John R. P. Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. P. Knight. John R. P. Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zijian, et al.. (2025). Causes and consequences of RNA:protein cross-links – lessons from chemotherapy. Emerging Topics in Life Sciences. 9(1). 1–11.
2.
Simms, Nicole & John R. P. Knight. (2023). RNA damage: the forgotten target of clinical compounds. 1. 4 indexed citations
3.
Knight, John R. P. & Owen J. Sansom. (2021). Tuning protein synthesis for cancer therapy. Molecular & Cellular Oncology. 8(2). 1884034–1884034. 5 indexed citations
4.
Kanellos, Georgios, Nikola Vlahov, Constantia Alexandrou, et al.. (2021). Translation initiation in cancer at a glance. Journal of Cell Science. 134(1). 30 indexed citations
5.
Mitchell, Louise, Kirsteen J. Campbell, Rachel A. Ridgway, et al.. (2019). Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas. Cell Death and Differentiation. 26(12). 2535–2550. 6 indexed citations
6.
Kugeratski, Fernanda G., Lisa J. Neilson, Sérgio Lilla, et al.. (2019). Hypoxic cancer–associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling. Science Signaling. 12(567). 94 indexed citations
7.
Marini, Alberto, Barak Rotblat, Thomas Sbarrato, et al.. (2018). TAp73 contributes to the oxidative stress response by regulating protein synthesis. Proceedings of the National Academy of Sciences. 115(24). 6219–6224. 27 indexed citations
8.
Monteverde, Tiziana, Jacqueline Tait-Mulder, Ann Hedley, et al.. (2017). Calcium signalling links MYC to NUAK1. Oncogene. 37(8). 982–992. 27 indexed citations
9.
Bastide, Amandine, Diego Peretti, John R. P. Knight, et al.. (2017). RTN3 Is a Novel Cold-Induced Protein and Mediates Neuroprotective Effects of RBM3. Current Biology. 27(5). 638–650. 55 indexed citations
10.
Knight, John R. P., Amandine Bastide, Diego Peretti, et al.. (2016). Cooling-induced SUMOylation of EXOSC10 down-regulates ribosome biogenesis. RNA. 22(4). 623–635. 26 indexed citations
11.
Somers, Joanna, Lindsay A. Wilson, John‐Paul Kilday, et al.. (2015). A common polymorphism in the 5′ UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy. Genes & Development. 29(18). 1891–1896. 32 indexed citations
12.
Hesketh, Emma L., John R. P. Knight, Rosemary H. C. Wilson, J. Chong, & Dawn Coverley. (2015). Transient association of MCM complex proteins with the nuclear matrix during initiation of mammalian DNA replication. Cell Cycle. 14(3). 333–341. 10 indexed citations
13.
Allison, Simon J., John R. P. Knight, Carlotta Granchi, et al.. (2014). Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways. Oncogenesis. 3(5). e102–e102. 109 indexed citations
14.
Knight, John R. P., Amandine Bastide, Anne Roobol, et al.. (2014). Eukaryotic elongation factor 2 kinase regulates the cold stress response by slowing translation elongation. Biochemical Journal. 465(2). 227–238. 37 indexed citations
15.
Knight, John R. P., Anne E. Willis, & Jo Milner. (2013). Active regulator of SIRT1 is required for ribosome biogenesis and function. Nucleic Acids Research. 41(7). 4185–4197. 18 indexed citations
16.
Shah, Zahid H., Shafiq U. Ahmed, Jack R. Ford, et al.. (2011). A Deacetylase-Deficient SIRT1 Variant Opposes Full-Length SIRT1 in Regulating Tumor Suppressor p53 and Governs Expression of Cancer-Related Genes. Molecular and Cellular Biology. 32(3). 704–716. 20 indexed citations
17.
Knight, John R. P. & Jo Milner. (2011). SIRT1, metabolism and cancer. Current Opinion in Oncology. 24(1). 68–75. 83 indexed citations
18.
Munkley, Jennifer, Nikki A. Copeland, Victoria Moignard, et al.. (2010). Cyclin E is recruited to the nuclear matrix during differentiation, but is not recruited in cancer cells. Nucleic Acids Research. 39(7). 2671–2677. 15 indexed citations
19.
Green, C. J., John R. P. Knight, Sophie V. Precious, & S. Simpkin. (1981). Ketamine alone and combined with diazepam or xylazine in laboratory animals: a 10 year experience. Laboratory Animals. 15(2). 163–170. 246 indexed citations
20.
Green, C. J., John R. P. Knight, Sophie V. Precious, & S. Simpkin. (1981). Metomidate, etomidate and fentanyl as injectable anaesthetic agents in mice. Laboratory Animals. 15(2). 171–175. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristiana Valle Breakdown of academic impact, for papers by Yukang Yuan Breakdown of academic impact, for papers by Minna Niittykoski Breakdown of academic impact, for papers by Yongqin Wu Breakdown of academic impact, for papers by Jessie M. Cameron Breakdown of academic impact, for papers by Nicola Beindorff Breakdown of academic impact, for papers by Patrick J. Gillespie Breakdown of academic impact, for papers by Jun Tanaka Breakdown of academic impact, for papers by Françoise Roux Breakdown of academic impact, for papers by Douglas J. Lamont
Rankless by CCL
2026